羊膜市場規模、佔有率和成長分析（按產品、應用、最終用途和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，羊膜市場規模將達到 51.8 億美元，到 2025 年將達到 59.6 億美元，到 2033 年將達到 183.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 15.1%。

羊膜因其在多種疾病治療中的療效以及改善手術效果，在醫療保健市場，尤其是眼科和整形外科專家中備受關注。相關疾病患者數量的不斷成長，推動了對創新羊膜產品的需求，以實現更有效率的手術介入。眼科手術中對組織基解決方案的日益關注，顯著促進了市場擴張，因為此類解決方案有助於患者術後復原。此外，美容手術的日益普及預計也將進一步推動市場成長。冷凍保存技術、生物工程以及生物相容性支架的開發等技術進步，正在提升羊膜的功能，增強其組織修復和再生能力，從而滿足醫療服務提供者和患者不斷變化的需求。

羊膜市場促進因素

戶外工作者嚴重受傷事件的不斷增加，是推動快速高效復健療法需求成長的主要因素。創傷性損傷，尤其是兒童和青少年創傷性損傷，主要由道路交通事故造成，而道路交通事故仍是亟待解決的問題。隨著全球對道路安全的日益關注和交通堵塞的加劇，交通事故的發生頻率也不斷上升。創傷性損傷病例的激增直接推動了羊膜市場的成長，因為醫療專業人員正在尋求先進的解決方案來促進此類損傷患者的康復和癒合。因此，羊膜市場正在蓬勃發展。

羊膜市場的限制

由於生產這些特殊產品及其相關服務的高成本，羊膜市場面臨嚴峻的挑戰。羊膜產品的生產需要複雜的生物過程和技術，這些對於確保安全性和保持其天然特性至關重要。嚴格的品管、全面的測試以及對監管標準的遵守是生產過程中的關鍵環節，這些因素共同導致了高昂的成本。由此產生的經濟負擔給患者、醫療服務提供者和醫療保健系統帶來了障礙，並可能限制這些寶貴治療方法的可近性和廣泛應用。

羊膜市場趨勢

羊膜市場正經歷顯著成長，這主要得益於新興經濟體，特別是亞太地區國家（如中國、印度和巴西）有利的醫療政策。這些地區的醫療基礎設施不斷完善，監管障礙降低，病患群體日益壯大。此外，不斷成長的醫療費用支出和有利於商業發展的管治環境也為市場相關人員創造了有利條件。對創新傷口創傷護理和外科手術應用的需求不斷成長，以及全球企業聚焦這些新興市場帶來的競爭格局的加劇，進一步提振了市場前景。隨著人們對羊膜治療益處的認知不斷提高，預計這些地區的投資機會也將隨之活性化。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球羊膜市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 冷凍保存的羊膜
• 脫水羊膜

全球羊膜市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 外科性創傷
• 眼科
• 其他

全球羊膜市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 醫院
• 門診手術中心
• 專科診所
• 研究和學術機構

全球羊膜市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• MiMedx Group, Inc.（USA）
• Integra LifeSciences Holdings Corporation.（USA）
• Organogenesis Holdings Inc.（USA）
• Smith & Nephew plc.（UK）
• BioTissue Holdings Inc.（USA）
• Amnio Technology, LLC.（USA）
• Applied Biologics LLC.（USA）
• Celularity Inc.（USA）
• Corza Health, Inc.（USA）
• Skye Biologics, Inc.（USA）
• Human Regenerative Technologies, LLC.（USA）
• Katena Products Inc.（USA）
• TissueTech Inc.（BioTissue）（USA）
• Amniox Medical Inc.（USA）
• Laboratoire CCD.（France）
• VIVEX Biologics Inc.（USA）
• Merakris Therapeutics.（USA）
• Thea Pharma.（France）
• Allosure, Inc.（USA）
• Xtant Medical Holdings Inc.（USA）

結論與建議

Amniotic Membrane Market size was valued at USD 5.18 Billion in 2024 and is poised to grow from USD 5.96 Billion in 2025 to USD 18.37 Billion by 2033, growing at a CAGR of 15.1% during the forecast period (2026-2033).

The amniotic membrane (AM) is gaining traction in the healthcare market, particularly among ophthalmology and orthopedic specialists, due to its efficacy in treating various conditions and enhancing surgical outcomes. The rising patient population with related diseases drives the demand for innovative amniotic membrane products, allowing for more efficient surgical interventions. The growing inclination for tissue-based solutions in ophthalmic surgeries significantly contributes to market expansion, as these products promote quicker patient recovery. Additionally, the increasing popularity of aesthetic surgical procedures is expected to further fuel market growth. Technological advancements, including cryopreservation, bioengineering, and the development of biocompatible scaffolds, are enhancing the functionality of amniotic membranes, thereby improving tissue repair and regeneration capabilities, which aligns with the evolving needs of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Amniotic Membrane market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Amniotic Membrane Market Segments Analysis

Global Amniotic Membrane Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane. Based on Application, the market is segmented into Surgical Wounds, Ophthalmology and Others. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Research Institutes and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Amniotic Membrane Market

The rising incidence of severe injuries among workers engaged in fieldwork is significantly driving the demand for swift and efficient healing therapies. Traumatic injuries, particularly among children and young adults, are predominantly caused by road accidents, which continue to be a pressing issue. With road safety concerns escalating and traffic congestion intensifying globally, the frequency of accidents is increasing. This surge in trauma cases directly contributes to the growth of the amniotic membrane market, as healthcare providers seek advanced solutions to facilitate recovery and healing for those affected by such injuries. As a result, the market for amniotic membranes is flourishing.

Restraints in the Amniotic Membrane Market

The amniotic membrane market faces significant challenges due to the high costs associated with producing these specialized products and their related services. The manufacturing of amniotic membrane products necessitates intricate biological processing and techniques that are essential for preserving their natural properties while ensuring safety. Maintaining stringent quality control, conducting thorough testing, and adhering to regulatory standards are crucial aspects of this production process, which collectively contribute to elevated expenses. As a result, the financial burden can create obstacles for patients, suppliers, and healthcare systems, potentially limiting access and adoption of these valuable therapies.

Market Trends of the Amniotic Membrane Market

The amniotic membrane market is witnessing significant growth driven by favorable healthcare policies in emerging economies, particularly in Asia-Pacific nations like China, India, and Brazil. These regions boast improved healthcare infrastructure, reduced regulatory barriers, and an expanding patient population. Additionally, increasing healthcare expenditures and pro-business governance create a conducive environment for market players. The burgeoning demand for innovative wound care and surgical applications, combined with a competitive landscape spurred by global players focusing on these emerging markets, further enhances market prospects. As awareness of the therapeutic benefits of amniotic membranes rises, investment opportunities in these regions are set to intensify.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Amniotic Membrane Market Size by Product & CAGR (2026-2033)

• Market Overview
• Cryopreserved Amniotic Membrane
• Dehydrated Amniotic Membrane

Global Amniotic Membrane Market Size by Application & CAGR (2026-2033)

• Market Overview
• Surgical Wounds
• Ophthalmology
• Others

Global Amniotic Membrane Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research Institutes and Academic Institutes

Global Amniotic Membrane Market Size & CAGR (2026-2033)

• North America (Product, Application, End Use)
  • US
  • Canada
• Europe (Product, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• MiMedx Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organogenesis Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTissue Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amnio Technology, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Biologics LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celularity Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corza Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skye Biologics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Regenerative Technologies, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Katena Products Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TissueTech Inc. (BioTissue) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amniox Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoire CCD. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VIVEX Biologics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merakris Therapeutics. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thea Pharma. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allosure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations